In clinical samples of bladder cancer, ANXA2 expression in T2 group was higher than ANXA2 expression in Tis-T1 group and ANXA2 expression in patients who recurred at < 6 months after initial surgery was significantly higher than ANXA2 expression in patients who recurred at > 2 years (Hu et al., 2016). This evidence concerns the gene ANXA2 and urinary bladder cancer.